The global biomarkers market was valued at $46.4 billion in 2023, and is projected to reach $134.2 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.
The global immunology market was valued at $110.1 billion in 2023, and is projected to reach $204.0 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033